Results for "Understanding Pharmaceutical Distribution"
Distributors Leading Efforts to Maintain Supply Chain Integrity
While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.
HDA Statement on PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) released a statement on the inclusion of the PREVENT Pandemics Act (Prepare for a Respond to Existing Viruses, Emerging New Threats, and Pandemics Act), as part of the Consolidated Appropriations Act.
HDA’s 2023 DMA Winners Discuss DSCSA Credentialing and the Value of Collaboration
With the Drug Supply Chain Security Act (DSCSA) implementation deadline on the horizon, HDA members and industry partners are driving innovative solutions to support trading partner compliance. One of the notable examples of this collaboration is demonstrated by HDA’s 2023 Distribution Management Award (DMA) recipients, Spherity and Legisym.
We spoke with Georg Jürgens, Spherity’s Manager of Industry Solutions, and David Kessler, President and Partner of Legisym, about their companies’ histories, award-winning DSCSA solution and collaboration driving innovation within the healthcare distribution supply chain.
Standard Pharmaceutical Product and Medical Device Information (Rx Product Only)
With member input, HDA has developed a standardized format for the information about new pharmaceutical and medical device products.